Saturday, Sep 23, 2023
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Education Today
    • Reviews
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Health | Study Reveals Obesity Drug May Decrease Type 2 Diabetes Risk

Study reveals obesity drug may decrease type 2 diabetes risk

The researchers of the study, to be presented at the annual meeting of the European Association for the Study of Diabetes (EASD), said semaglutide reduces the future risk of diabetes by over 60 per cent in patients with obesity.

By IANS
Published Date - 02:25 PM, Mon - 12 September 22
Study reveals obesity drug may decrease type 2 diabetes risk
whatsapp facebook twitter telegram

New York: The risk of type 2 diabetes is more than halved by weekly injections of the new obesity drug semaglutide, which was recently approved in the US and has been provisionally approved in England, says a new study.

The researchers of the study, to be presented at the annual meeting of the European Association for the Study of Diabetes (EASD), said semaglutide reduces the future risk of diabetes by over 60 per cent in patients with obesity.

“Semaglutide appears to be the most effective medication to date for treating obesity and is beginning to close the gap with the amount of weight loss following bariatric surgery,” said researcher W. Timothy Garvey from the University of Alabama at Birmingham in the US.

Obesity is known to increase the risk of type 2 diabetes at least six-fold and the team was interested in understanding whether semaglutide could reduce this risk. To learn more, they conducted a new analysis of the data from two trials of semaglutide.

In STEP 1, 1,961 overweight or obese participants received an injection of 2.4 mg of semaglutide or a placebo weekly, for 68 weeks.

STEP 4 involved 803 participants with overweight or obesity. All received weekly injections of 2.4 mg semaglutide for 20 weeks. They then either remained on semaglutide or were switched to placebo for the next 48 weeks.

In STEP 1 participants receiving semaglutide, 10-year risk scores for type 2 diabetes decreased by 61 per cent (from 18.2 per cent at week 0 to 7.1 per cent at week 68). This compares to a 13 per cent reduction in risk score for those given the placebo (17.8 per cent at week +0 to 15.6 per cent at week 68).

In the STEP 4 participants, the largest decreases in risk scores were seen in the first 20 weeks (from 20.6 per cent at week 0 to 11.4 per cent at week 20). In those who continued receiving semaglutide, the risk score decreased further to 7.7 per cent but in those who were switched to placebo, it rose to 15.4 per cent.

    Also Read

  • Health concerns men should keep track of
  • Covid survivors likely to develop heart diseases, diabetes in 3 months
  • Less carbs, more protein enough to reverse diabetes: Study
Telangana Today Whatsapp
  • Follow Us :
  • Tags
  • drug semaglutide
  • type 2 diabetes

Related News

  • Fermented tea drink ‘kombucha’ may lower blood sugar levels in patients with type 2 diabetes

    Fermented tea drink ‘kombucha’ may lower blood sugar levels in patients with type 2 diabetes

  • Belly fat may not increase diabetes risk for everyone, says study

    Belly fat may not increase diabetes risk for everyone, says study

  • Rising junk food consumption leads to alarming diabetes spiral

    Rising junk food consumption leads to alarming diabetes spiral

  • Deep sleep brain waves can predict next-day blood sugar levels

    Deep sleep brain waves can predict next-day blood sugar levels

  • Type 2 diabetes medicine may treat autoimmune disorders: Study

    Type 2 diabetes medicine may treat autoimmune disorders: Study

  • WHO advises against use of artificial sweeteners for weight loss. Here’s why

    WHO advises against use of artificial sweeteners for weight loss. Here’s why

Latest News

  • Rising Dengue cases prompt urgent preventive measures in Hyderabad

    4 mins ago
  • Sachin Tendulkar gifts Indian cricket team jersey to PM Modi in Varanasi

    6 mins ago
  • Heroin worth nearly Rs 37 lakh seized, six held in Assam 

    10 mins ago
  • DUSU Elections 2023: ABVP wins three seats, NSUI bags Vice President post

    26 seconds ago
  • Aamir Khan donates Rs 25 lakh towards Himachal Pradesh state disaster relief fund

    13 mins ago
  • Focus on Praggnanandhaa as India begins campaign in chess at Asian Games

    16 mins ago
  • Investing in credit cooperative societies turns risky in Mancherial

    17 mins ago
  • Manal clinches U-17 girl’s singles title at DRS International School Tennis Tournament

    20 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam